AlphaHunt
Healthcare

LLY Stock Analysis

Eli Lilly and Company · current price $1112.10 (-0.92% today)

★★★★★ Top Tier 72/ Alpha Score
Top-tier setup — 56% revenue growth, +13% 30-day momentum, 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned.
LAST EARNINGS Eli Lilly and Company (LLY)

Latest earnings

EPS
$6.31 vs $5.59 est · +0.1% vs estimate BEAT
Revenue
$19.80B · +27.3% YoY
Stock reaction (1M)
+12.6%
Beat streak
4 of last 4 quarters

Key metrics

Alpha Score
72/100
Grade
A
Rev Growth YoY
+55.5%
30-day Momentum
+12.6%
Forward P/E
39.5×
Analyst Target
$1215.79
Implied Upside
+9.3%

Latest news on LLY

Similar stocks in Healthcare

BIIB WST WAT MRNA HOLX DGX

View all Healthcare stocks →

LLY — frequently asked

What is LLY's Alpha Score?

Eli Lilly and Company (LLY) currently has a TickerMover Alpha Score of 72/100, rated ★★★★★ Top Tier. The Alpha Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is Eli Lilly and Company (LLY) a buy?

TickerMover does not give buy or sell recommendations. LLY scores 72/100 (★★★★★ Top Tier) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is LLY's score updated?

LLY's Alpha Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF, peer comparison and more — free during beta.

Open dashboard for LLY →
TickerMover is a research tool, not financial advice. Alpha Score is a composite signal — always do your own research before investing.
Last updated automatically every 5 minutes during US market hours.
Questions? support@tickermover.com